New CTO in Fermentationexperts

Søren Kjærulff appointed new CTO in Fermentationexperts AS

Fermentationexperts AS has announced the appointment of Søren Kjærulff as its Chief Technical Officer (CTO) for human applications. In parallel with this position, Søren is also appointed CEO of Good4Guts ApS, which is a new company where the development, production and sales of products for human use will be placed. He will assume the responsibilities on 1 June 2017.
In order to meet the strategic aims of the company it has been decided to create this new position. Many new devel-opment initiatives are initiated and additional competencies are needed in order to meet the grow prospects.
“I am pleased to announce that we now have found our new CTO for human applications as well as CEO of our new sister company, Good4Guts, says Jens Legarth, CEO. “By employing Søren Kjærulff, Fermentationexperts will get a strong CTO with huge experience in the fields of biopharma R&D, business development, and products for human applications”.
Søren Kjærulff comes from a position as Director in Novozymes where he has been responsible for Biopharma R&D and discovery and development of antibacterial and anti-inflammatory drug candidates and lately also responsible for building a lactic acid bacteria platform. Moreover, Søren has a Ph.D from Copenhagen University in molecular biology. Søren has published several scientific papers, and he is the co-inventor of several patents.
“Jens and I have had the opportunity to meet on different occasions in relation to our participations in research projects nationally and internally. It is clear for both of us that our competencies complement each other very well and we see a great potential in the existing products applied for human use”, says Søren Kjærulff.
In Good4Guts it is expected that we will be able to deliver products to people suffering from different kinds of diseases related to intestine health e.g. inflammatory bowel diseases, type 2 diabetes, cardiovascular disease, obesity, staph-ylococci, and streptococci infections etc. “The preliminary results are very positive and hopefully we will have products on the market soon”, says Jens Legarth.
“I have been very positive surprised by the many data generated by Fermentationexperts and scientific collaborators and I am looking very much forward to be part of the fantastic development of fermented products for the human health area,” says Søren Kjærulff.
Facts
With production plants located worldwide, Fermentationexperts works with universities and key biotechnology players to create lactic acid fermented feed and health solutions that make a difference. It is now in the early stages of developing fermented health products for human applications. Please visit our company website for further infor-mation: www.fermentationexperts.com
For additional information

Download PDF file here.

Jens Legarth, CEO, phone: +45 2334 9334 or e-mail: jel@fexp.eu
Søren Kjærulff, CTO, phone: +45 3133 4080 or e-mail: sk@fexp.eu